MGI Pharma-SuperGen in Cancer-Drug Deal
232138
MGI Pharma Inc. MOGN.O will spend up  to $85 million for a stake in SuperGen Inc. SUPG.O and global  rights to develop and sell SuperGen's experimental drug for an  often-fatal cancer of the bone marrow, the companies said on  Wednesday.
766094
DUBLIN/NEW YORK  - Patients taking an experimental  multiple sclerosis drug developed by Biogen Idec Inc. BIIB.O  and Elan Corp. ELN.I experienced far fewer relapses in a  clinical trial, data that analysts say could give the drug a  dominant market position.
262304
Shares of Genentech Inc. DNA.N, OSI  Pharmaceuticals Inc. OSIP.O and ImClone Systems Inc. IMCL.O  surged before the bell on Friday after rival AstraZeneca Plc  AZN.L said its lung cancer drug Iressa failed to show  survival benefits in a major clinical study.
644015
Biotechnology stocks moved higher Wednesday, led by MGI Pharma Inc., which agreed to buy a stake in SuperGen Inc. as part of a licensing deal for SuperGen&#39;s Dacogen drug.
752627
Merck KGaA's cancer drug cilengitide  showed encouraging results in a Phase I study in the treatment  of glioma, an aggressive form of brain tumor, the German drugs  and chemicals group said on Monday.
735577
Shares in OSI Pharmaceuticals (OSIP :Nasdaq - news - research) and Genentech (DNA :Nasdaq - news - research) jumped Friday after AstraZeneca (AZN :NYSE - news - research) said new medical data showed its lung cancer drug Iressa provided no survival
184796
Shares of OSI Pharmaceuticals Inc.  OSIP.O jumped 13 percent in pre-market trade on Monday after  the company's experimental drug was shown to prolong the lives  of patients with cancer of the pancreas.
747218
Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC.
428394
French drugmaker Sanofi-Aventis and Japan's Taiho Pharmaceutical said combining their S-1 oral stomach cancer medicine with the drug cisplatin improved chances of survival compared with S-1 alone.
207285
Pfizer Inc. PFE.N has signed a deal  with Schering AG SCHG.DE granting it a worldwide license to  Schering's ADP receptor antagonist program, the U.S. drug maker  said on Wednesday.
738382
The drug maker is poised to speed past its rivals.
360178
MedImmune Inc. said yesterday that it would pay a Massachusetts drug company up to $500 million for the rights to co-develop and sell new cancer treatments.
723657
Could a jointly marketed drug lead to a joint company? Ireland&#39;s Sunday Tribune said yesterday that US pharmaceuticals company Biogen Idec (nasdaq: BIIB - news - people ) was looking to make an all-stock bid
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
181860
Platforms have the potential to develop multiple drugs for a company.
639985
As part of its push to become a bigger player in cancer drugs, Genzyme Corp. of Cambridge said yesterday it will buy out business partner Bioenvision Inc. of New York for $345 million , consolidating its ownership of a cancer treatment to which the two companies had been sharing rights.
719897
The move appeared to be a competitive strategy and based on public concerns about the costs of new cancer drugs.